MSB 0.00% $1.74 mesoblast limited

This is a stem cell company, but so what? It still has to...

  1. 149 Posts.
    lightbulb Created with Sketch. 32
    This is a stem cell company, but so what? It still has to overcome the same hurdles as any other organisation developing therapeutics. And in direct response to your point: the world is awash with drugs that successfully got through Phase 3, whereas it is NOT awash with stem cell therapeutics. On the contrary, there have been multiple failures.
    As we've discussed and (gasp!) agreed previously, stem cells are unquestioningly safe to administer. The question as to whether they are efficacious will remain moot until such time as they have successfully negotiated a Phase 3 programme. You seem to think that this is a slam dunk, presumably based upon the post-hoc analysis of the Phase 2 data, but then you think that the stem cell DNA interreacts with biologicalisation high up the pharmaceuticaloid chainosomes. Or something. I confess, I'm a little hazy on the precise details of your scientific rationale.

    And now, I can't be bothered with you again any more.
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.128B
Open High Low Value Volume
$1.72 $1.75 $1.70 $3.782M 2.192M

Buyers (Bids)

No. Vol. Price($)
2 17102 $1.74

Sellers (Offers)

Price($) Vol. No.
$1.75 12000 1
View Market Depth
Last trade - 16.10pm 14/05/2021 (20 minute delay) ?
0.000 ( 0.93 %)
Open High Low Volume
$1.73 $1.76 $1.70 540314
Last updated 15.59pm 14/05/2021 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.